SEC Form 4 · accession 0001140361-16-080656
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashley C. Gould
Officer — Chief Legal Officer
Period of report
Jul 15, 2016
Accepted (ET)
Sep 23, 2016 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 15, 2016 | F | 3,125 | $6.02 | D | 45,976 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by Raptor to satisfy tax withholding obligations applicable to vesting of 8,313 stock-settled restricted stock units.